Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...

Forma Life Sciences has launched as an independent, operator-owned contract development and manufacturing organization (CDMO) in the U.S. The new CDMO is focused on oral solid dosage formulation ...

WADSWORTH, OH, UNITED STATES, March 5, 2026 /EINPresswire.com/ -- As manufacturers increasingly search for “rubber ...

Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...

Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication.Phase 1 clinical trial of the patent-pending, rapid-onset formulation ...

Forma Life Sciences today announced its launch as an independent contract development ad manufacturing organization.

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily ...

Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these compounds ...

Altruist Biologics, an Innovent Biologics subsidiary and world-class contract development and manufacturing organization (CDMO), recently announced the launch of Altru-CON, a high-concentration ...

BioTechnique broadens capabilities with end‑to‑end fill‑finish, advanced lyophilization development, and integrated multi‑temperature 3PL support. YORK, PA, UNITED STATES, March 5, 2026 /EINPresswire.

Altru-CON harnesses proprietary excipient blends and expertise to maximize drug delivery and stability through high-concentration formulation.The platform can reduce IND timelines to under nine ...

This article explores current OSD development and manufacturing trends from a CDMO perspective, including the evolution of ...